Food Allergy Fund Joins Elite National Innovation Networks to Fast-Track Breakthrough Treatments

Dual memberships in ARPA-H’s Investor Catalyst Hub and the Milken Institute’s FasterCures’ Research Acceleration and Innovation Network (TRAIN) strengthen the fight against the global food allergy crisis

New York, NY – September 2, 2025 – The Food Allergy Fund (FAF) now stands alongside national leaders as a spoke (participating organization) of the Advanced Research Projects Agency for Health (ARPA-H) Investor Catalyst Hub and as a member of the Milken Institute’s FasterCures’ Research Acceleration and Innovation Network (TRAIN)—two of the most influential collaborative networks driving health breakthroughs in the United States.

These memberships place FAF at the heart of bold, high-impact innovation efforts. They connect FAF with top scientists, innovators, and funders to tackle one of today’s fastest-growing public health crises: food allergies, which affect 33 million Americans and more than 300 million people worldwide.

“We're honored to join this powerful network of bold, strategic, and impact-focused leaders driving change across the health landscape,” said Ilana Golant, founder and CEO of the Food Allergy Fund. “Our mission is to help shorten the path from discovery to impact, not just for food allergies, but for the many immune-related diseases they intersect with. We are eager to collaborate on new ideas, increase funding, and ensure food allergy research receives the attention it deserves to bring hope to millions of families worldwide.”

Joining Forces with National Leaders in Innovation:

• The ARPA-H Investor Catalyst Hub is a nationwide network designed to speed the development of groundbreaking advances in science and medicine, connecting partners across government, academia, nonprofits, and industry. 

• The Milken Institute’s FasterCures’ TRAIN  stands out as a distinctive consortium of more than 180 patient-driven, nonprofit foundations that are rapidly emerging as the driving force behind cutting-edge disease research. It embodies collaboration, a mission-driven focus, strategic resource allocation, and a results-oriented approach, paving the way for advancements in medical research. 

###

About the Food Allergy Fund

The Food Allergy Fund (FAF) is the leading nonprofit dedicated to funding cutting-edge research to prevent, diagnose, and treat food allergies—a growing public health crisis affecting 10 percent of people in the United States and more than 300 million worldwide. Through competitive research grants and convening global thought leaders at its annual summits, FAF unites scientists, policymakers, industry leaders, and entrepreneurs to accelerate breakthroughs. FAF's mission is to create a future where no one has to suffer from food allergies. Learn more at www.foodallergyfund.org.

Media Contact: Amy DiElsi, Director of Communications, amy.dielsi@foodallergyfund.org